Literature DB >> 17453634

An epigenetic analysis of SOD1 and VEGF in ALS.

Nathan Oates1, Roger Pamphlett.   

Abstract

Epigenetic silencing of a gene vital for motor neuron function could underlie sporadic ALS. We therefore examined the methylation status of two genes, SOD1 and VEGF, which are implicated in ALS. Methylation in the promoters of these genes was determined in white cell DNA (10 ALS patients) and brain DNA (six ALS patients). The promoter regions were largely unmethylated in all patients. Transcriptional silencing of these genes is therefore unlikely to be a common mechanism in ALS. However, in view of the potential for treatment of epigenetic disorders, promoter methylation in other genes required for motor neuron survival needs to be studied.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17453634     DOI: 10.1080/17482960601149160

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  17 in total

Review 1.  Regulation of CuZnSOD and its redox signaling potential: implications for amyotrophic lateral sclerosis.

Authors:  Michael J Hitchler; Frederick E Domann
Journal:  Antioxid Redox Signal       Date:  2013-08-01       Impact factor: 8.401

Review 2.  Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms.

Authors:  Lee J Martin; Margaret Wong
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

3.  Epigenetic regulation of motor neuron cell death through DNA methylation.

Authors:  Barry A Chestnut; Qing Chang; Ann Price; Catherine Lesuisse; Margaret Wong; Lee J Martin
Journal:  J Neurosci       Date:  2011-11-16       Impact factor: 6.167

Review 4.  Adenosine deaminase, not immune to a mechanistic rethink in central nervous system disorders?

Authors:  Benjamin Hall; Jonathan G George; Scott P Allen
Journal:  Histol Histopathol       Date:  2021-12-09       Impact factor: 2.303

Review 5.  Genetics of motor neuron disorders: new insights into pathogenic mechanisms.

Authors:  Patrick A Dion; Hussein Daoud; Guy A Rouleau
Journal:  Nat Rev Genet       Date:  2009-10-13       Impact factor: 53.242

Review 6.  Regulation of superoxide dismutase genes: implications in disease.

Authors:  Lu Miao; Daret K St Clair
Journal:  Free Radic Biol Med       Date:  2009-05-25       Impact factor: 7.376

Review 7.  ALS and FTD: an epigenetic perspective.

Authors:  Veronique V Belzil; Rebecca B Katzman; Leonard Petrucelli
Journal:  Acta Neuropathol       Date:  2016-06-09       Impact factor: 17.088

8.  Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities.

Authors:  Sheila K Pirooznia; Felice Elefant
Journal:  Front Cell Neurosci       Date:  2013-03-28       Impact factor: 5.505

9.  Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis.

Authors:  Claudia Figueroa-Romero; Junguk Hur; Diane E Bender; Colin E Delaney; Michael D Cataldo; Andrea L Smith; Raymond Yung; Douglas M Ruden; Brian C Callaghan; Eva L Feldman
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.752

Review 10.  The importance of brain banks for molecular neuropathological research: The New South Wales Tissue Resource Centre experience.

Authors:  Irina Dedova; Antony Harding; Donna Sheedy; Therese Garrick; Nina Sundqvist; Clare Hunt; Juliette Gillies; Clive G Harper
Journal:  Int J Mol Sci       Date:  2009-01-23       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.